Jahr Robert Charles bought OTLK
August 14, 2026 · Form 4 insider transaction
Jahr Robert Charles bought 151,515 shares of Outlook Therapeutics, Inc., a transaction worth N/A. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
151,515
Price
N/A
Total value
N/A
InsiderJahr Robert Charles
RoleOfficer
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateAugust 14, 2026
Filing dateAugust 14, 2026
Shares owned after151,515
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On August 14, 2026, the reporting person acquired 151,515 shares of common stock and accompanying warrants to purchase 151,515 shares of common stock in the Issuer's underwritten public offering of shares of common stock and accompanying warrants for a combined public offering price of $0.99 per share of common stock and accompanying warrant.